-
Je něco špatně v tomto záznamu ?
The Emerging Role of Noncoding RNAs in Pediatric Inflammatory Bowel Disease
P. Jabandziev, J. Bohosova, T. Pinkasova, L. Kunovsky, O. Slaby, A. Goel
Jazyk angličtina Země Velká Británie
Typ dokumentu úvodní články, Research Support, N.I.H., Extramural, práce podpořená grantem
Grantová podpora
R01 CA184792
NCI NIH HHS - United States
R01 CA202797
NCI NIH HHS - United States
PubMed
32009179
DOI
10.1093/ibd/izaa009
Knihovny.cz E-zdroje
- MeSH
- biologické markery analýza MeSH
- Crohnova nemoc genetika MeSH
- dítě MeSH
- genetické markery genetika MeSH
- idiopatické střevní záněty genetika MeSH
- individualizovaná medicína trendy MeSH
- lidé MeSH
- nekódující RNA analýza MeSH
- signální transdukce genetika MeSH
- transkriptom MeSH
- ulcerózní kolitida genetika MeSH
- Check Tag
- dítě MeSH
- lidé MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- Publikační typ
- práce podpořená grantem MeSH
- Research Support, N.I.H., Extramural MeSH
- úvodní články MeSH
Prevalence of inflammatory bowel disease (IBD), a chronic inflammatory disorder of the gut, has been on the rise in recent years-not only in the adult population but also especially in pediatric patients. Despite the absence of curative treatments, current therapeutic options are able to achieve long-term remission in a significant proportion of cases. To this end, however, there is a need for biomarkers enabling accurate diagnosis, prognosis, and prediction of response to therapies to facilitate a more individualized approach to pediatric IBD patients. In recent years, evidence has continued to evolve concerning noncoding RNAs (ncRNAs) and their roles as integral factors in key immune-related cellular pathways. Specific deregulation patterns of ncRNAs have been linked to pathogenesis of various diseases, including pediatric IBD. In this article, we provide an overview of current knowledge on ncRNAs, their altered expression profiles in pediatric IBD patients, and how these are emerging as potentially valuable clinical biomarkers as we enter an era of personalized medicine.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc21026680
- 003
- CZ-PrNML
- 005
- 20211026132711.0
- 007
- ta
- 008
- 211013s2020 xxk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1093/ibd/izaa009 $2 doi
- 035 __
- $a (PubMed)32009179
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Jabandziev, Petr $u Department of Pediatrics, University Hospital Brno, Faculty of Medicine, Masaryk University, Brno, Czech Republic $u Central European Institute of Technology, Masaryk University, Brno, Czech Republic
- 245 14
- $a The Emerging Role of Noncoding RNAs in Pediatric Inflammatory Bowel Disease / $c P. Jabandziev, J. Bohosova, T. Pinkasova, L. Kunovsky, O. Slaby, A. Goel
- 520 9_
- $a Prevalence of inflammatory bowel disease (IBD), a chronic inflammatory disorder of the gut, has been on the rise in recent years-not only in the adult population but also especially in pediatric patients. Despite the absence of curative treatments, current therapeutic options are able to achieve long-term remission in a significant proportion of cases. To this end, however, there is a need for biomarkers enabling accurate diagnosis, prognosis, and prediction of response to therapies to facilitate a more individualized approach to pediatric IBD patients. In recent years, evidence has continued to evolve concerning noncoding RNAs (ncRNAs) and their roles as integral factors in key immune-related cellular pathways. Specific deregulation patterns of ncRNAs have been linked to pathogenesis of various diseases, including pediatric IBD. In this article, we provide an overview of current knowledge on ncRNAs, their altered expression profiles in pediatric IBD patients, and how these are emerging as potentially valuable clinical biomarkers as we enter an era of personalized medicine.
- 650 _2
- $a biologické markery $x analýza $7 D015415
- 650 _2
- $a dítě $7 D002648
- 650 _2
- $a ulcerózní kolitida $x genetika $7 D003093
- 650 _2
- $a Crohnova nemoc $x genetika $7 D003424
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a genetické markery $x genetika $7 D005819
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a idiopatické střevní záněty $x genetika $7 D015212
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a individualizovaná medicína $x trendy $7 D057285
- 650 _2
- $a nekódující RNA $x analýza $7 D022661
- 650 _2
- $a signální transdukce $x genetika $7 D015398
- 650 _2
- $a transkriptom $7 D059467
- 655 _2
- $a úvodní články $7 D054711
- 655 _2
- $a Research Support, N.I.H., Extramural $7 D052061
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Bohosova, Julia $u Central European Institute of Technology, Masaryk University, Brno, Czech Republic
- 700 1_
- $a Pinkasova, Tereza $u Department of Pediatrics, University Hospital Brno, Faculty of Medicine, Masaryk University, Brno, Czech Republic
- 700 1_
- $a Kunovsky, Lumir $u Department of Gastroenterology and Internal Medicine, University Hospital Brno, Faculty of Medicine, Masaryk University, Brno, Czech Republic $u Department of Surgery, University Hospital Brno, Faculty of Medicine, Masaryk University, Brno, Czech Republic
- 700 1_
- $a Slaby, Ondrej $u Central European Institute of Technology, Masaryk University, Brno, Czech Republic
- 700 1_
- $a Goel, Ajay $u Department of Molecular Diagnostics and Experimental Therapeutics, Beckman Research Institute of City of Hope Comprehensive Cancer Center, Duarte, California, USA
- 773 0_
- $w MED00002243 $t Inflammatory bowel diseases $x 1536-4844 $g Roč. 26, č. 7 (2020), s. 985-993
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/32009179 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20211013 $b ABA008
- 991 __
- $a 20211026132718 $b ABA008
- 999 __
- $a ok $b bmc $g 1715424 $s 1147187
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2020 $b 26 $c 7 $d 985-993 $e 20200618 $i 1536-4844 $m Inflammatory bowel diseases $n Inflamm Bowel Dis $x MED00002243
- GRA __
- $a R01 CA184792 $p NCI NIH HHS $2 United States
- GRA __
- $a R01 CA202797 $p NCI NIH HHS $2 United States
- LZP __
- $a Pubmed-20211013